Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Neurofeedback has begun to attract the attention and scrutiny of the scientific and medical mainstream. Here, neurofeedback researchers present a consensus-derived checklist that aims to improve the reporting and experimental design standards in the field.
Original languageEnglish
Pages (from-to)1674-1685
JournalBrain
Volume143
Issue number6
DOIs
Publication statusPublished - 16 Mar 2020

Funding

U.S. has been paid for public speaking by Novartis, Medice, NeuroCare, the German Society for Biofeedback, the German Society for Psychotherapy and Psychiatry and the Akademie König und Müller. K.R. has received a grant from Takeda for another project. M.H. has a patent application for fNIRS neu-rofeedback, titled ‘Methods and systems for treating a subject using NIRS neurofeedback’ (PCT/US2017/036532, filed June 8, 2017) as well as a contract with Elsevier to edit a book titled ‘FMRI Neurofeedback’. D.B. serves as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work. B.B. was paid for public speaking by the neuroCare Group (München, Germany). M.A. is unpaid chairman of the Brainclinics Foundation, a minority shareholder in neuroCare Group (Munich, Germany), and a co-inventor on four patent applications related to EEG, neuromodulation and psychophysiology, but receives no royalties related to these patents; Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia), Urgotech (France) and neuroCare Group (München, Germany), and equipment support from Deymed, neuroConn, Brainsway and Magventure. R.T.T. has received payments to consult with neurofeedback start-up companies. R.C.D. holds patents related to rtfMRI and rtfMRI-based feedback, and is CEO and a shareholder in Omneuron, a company that has developed technology related rtfMRI-based feedback. All other authors report no competing interests. No funding was received towards this work. R.T.T. is supported by a postdoctoral fellowship from the Fonds de la recherche en santé du Québec. A.O. and M.A.L. are supported by the Center for Bioelectric Interfaces National Research University Higher School of Economics, Russian Federation Government grant, ag. No.14.641.31.0003.

FundersFunder number
Center for Bioelectric Interfaces National Research University Higher School of Economics, Russian Federation Government14.641.31.0003
National Eye InstituteR01EY028746
Takeda Pharmaceutical Company
Fonds de Recherche du Québec - Santé
neuroCare Group

    Fingerprint

    Dive into the research topics of 'Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)'. Together they form a unique fingerprint.

    Cite this